The ONLY Way to Play Markets Like These

From Oxford Club | Ad

The best investor in the world knows the only way to prosper (especially in markets like these)... is to invest in VALUE. But this $2 stock could be the last value play in the market today.

See Why This $2 Stock Could Be $50 and STILL Be a Bargain.

Click here.

ONCS Insider Trading (OncoSec Medical)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 2.73%

Insider Buying (Last 12 Months): $23,040.00

Insider Selling (Last 12 Months): $1,389.23

OncoSec Medical Insider Trading History Chart

OncoSec Medical Share Price & Price History

^$0.72

▼ -0.0209 (-2.82%)

As of 08/15/2022 06:19 PM ET

Days: 30 | 90 | 365

WARNING: Do You Invest with these Banks

From Behind the Markets | Ad

Take a close look at these investment banks. Because if you own stocks with any of these brokerages...

This new political development WILL affect you.

If you invest with any of these brokerage firms, click here to see how to protect your portfolio from this new conflict.

>>>

OncoSec Medical Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/5/2022	Robert J. DelAversano	VP	Sell	284	$0.71	$201.64	23,258
5/6/2022	Robert J. DelAversano	VP	Sell	274	$0.83	$227.42	23,542
2/9/2022	Robert J. DelAversano	VP	Sell	409	$0.88	$359.92
11/1/2021	Robert J. DelAversano	VP	Sell	343	$1.75	$600.25
8/23/2021	Yuhang Zhao	Director	Buy	4,000	$1.88	$7,520.00	8,000
8/20/2021	Yuhang Zhao	Director	Buy	8,000	$1.94	$15,520.00
8/2/2021	Robert J. Delaversano	VP	Sell	412	$2.18	$898.16	24,568
6/28/2021	Brian A. Leuthner	CEO	Sell	13,613	$3.16	$43,017.08	192,000
5/3/2021	Robert J. DelAversano	VP	Sell	453	$4.86	$2,201.58	24,980
4/30/2021	Daniel J. O'Connor	CEO	Sell	3,172	$4.86	$15,415.92	96,097
4/16/2021	Grand Pharmaceutical & H China	Major Shareholder	Buy	1,691,806	$3.45	$5,836,730.70
2/1/2021	Daniel J. O'Connor	CEO	Sell	3,413	$7.71	$26,314.23	99,269
1/25/2021	Grand Pharmaceutical & H China	Major Shareholder	Buy	4,067,037	$5.45	$22,165,351.65
11/20/2020	Alpha Holdings, Inc.	Director	Sell	80,000	$4.92	$393,600.00	1,350,001
11/18/2020	Alpha Holdings, Inc.	Director	Sell	10,999	$5.24	$57,634.76	1,480,001
11/16/2020	Alpha Holdings, Inc.	Director	Sell	40,000	$5.41	$216,400.00
11/2/2020	Daniel J. O'Connor	CEO	Sell	3,280	$3.79	$12,431.20	102,682
8/19/2020	Grand Pharmaceutical & H China	Major Shareholder	Buy	2,398,800	$3.25	$7,796,100.00
7/31/2020	Daniel J. O'Connor	CEO	Sell	3,133	$4.20	$13,158.60	105,962
4/30/2020	Daniel J. O'Connor	CEO	Sell	3,075	$1.79	$5,504.25	62,986
1/31/2020	Daniel J. O'Connor	CEO	Sell	2,654	$1.96	$5,201.84	66,061
1/16/2020	Sara Bonstein	CFO	Sell	1,351	$2.08	$2,810.08	41,389
10/31/2019	Daniel J. O'Connor	CEO	Sell	2,128	$2.16	$4,596.48	68,715
10/16/2019	Sara Bonstein	CFO	Sell	1,111	$2.01	$2,233.11	42,740

A One Stop Shop for Everything Futures Trading

From RJO Futures | Ad

Whether you're looking to learn the basics of futures or are a seasoned vet looking to hone your trading skills, our Technical Analysis Guide has everything you need to succeed in today's futures markets!

Download your FREE Technical Analysis Trading Guide Today.

SEC Filings (Institutional Ownership Changes) for OncoSec Medical (NASDAQ:ONCS)

13.98% of OncoSec Medical stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

OncoSec Medical Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/13/2022	Renaissance Technologies LLC	72,898	$54K	0.0%	+48.8%	0.185%
5/13/2022	Renaissance Technologies LLC	48,998	$56K	0.0%	-80.4%	0.125%
5/11/2022	Bank of New York Mellon Corp	386,074	$0.44M	0.0%	+653.7%	0.981%
5/10/2022	Salzhauer Michael	296,282	$0.34M	0.2%	-7.8%	0.753%
4/13/2022	Sandbox Financial Partners LLC	27,500	$32K	0.0%	-56.0%	0.070%
2/14/2022	Long Focus Capital Management LLC	69,226	$66K	0.0%	N/A	0.176%
2/4/2022	Salzhauer Michael	321,354	$0.31M	0.1%	+15.9%	0.817%
1/31/2022	D.A. Davidson & CO.	57,500	$55K	0.0%	-47.0%	0.146%
11/16/2021	Schonfeld Strategic Advisors LLC	25,400	$55K	0.0%	-28.0%	0.065%
11/16/2021	Two Sigma Advisers LP	361,401	$0.77M	0.0%	+128.2%	0.922%
11/15/2021	Tocqueville Asset Management L.P.	49,500	$0.11M	0.0%	+86.8%	0.126%
11/15/2021	HighTower Advisors LLC	20,705	$45K	0.0%	N/A	0.053%
9/17/2021	Virtu Financial LLC	12,649	$36K	0.0%	N/A	0.032%
8/17/2021	Boothbay Fund Management LLC	45,370	$0.13M	0.0%	N/A	0.116%
8/17/2021	Caxton Corp	159,935	$0.45M	0.3%	+38.0%	0.408%
8/16/2021	Schonfeld Strategic Advisors LLC	35,300	$99K	0.0%	-15.6%	0.090%
8/16/2021	State Street Corp	19,929	$56K	0.0%	N/A	0.051%
8/16/2021	Shay Capital LLC	25,057	$70K	0.0%	N/A	0.064%
8/16/2021	Tocqueville Asset Management L.P.	26,500	$74K	0.0%	+29.3%	0.068%
8/13/2021	Renaissance Technologies LLC	391,505	$1.10M	0.0%	+14.9%	0.999%
8/13/2021	Jump Financial LLC	20,200	$57K	0.0%	+90.6%	0.052%
8/13/2021	Geode Capital Management LLC	183,322	$0.52M	0.0%	+29.7%	0.468%
8/13/2021	Vanguard Group Inc.	688,263	$1.94M	0.0%	-20.9%	1.756%
8/6/2021	Salzhauer Michael	47,303	$0.13M	0.1%	+26.8%	0.121%
8/5/2021	GSA Capital Partners LLP	29,643	$83K	0.0%	N/A	0.076%
8/4/2021	Envestnet Asset Management Inc.	13,486	$38K	0.0%	N/A	0.034%
5/21/2021	Citadel Advisors LLC	17,903	$86K	0.0%	+38.0%	0.048%
5/19/2021	Squarepoint Ops LLC	52,024	$0.25M	0.0%	N/A	0.140%
5/18/2021	Millennium Management LLC	171,357	$0.82M	0.0%	+184.6%	0.461%
5/18/2021	Citadel Advisors LLC	17,903	$86K	0.0%	+38.0%	0.048%
5/18/2021	Holocene Advisors LP	642,476	$3.07M	0.0%	N/A	1.729%
5/17/2021	Schonfeld Strategic Advisors LLC	41,800	$0.20M	0.0%	-60.6%	0.112%
5/17/2021	HRT Financial LP	15,699	$74K	0.0%	N/A	0.042%
5/13/2021	Renaissance Technologies LLC	340,706	$1.63M	0.0%	+6.8%	0.917%
5/12/2021	Northern Trust Corp	43,358	$0.21M	0.0%	+58.8%	0.117%
5/12/2021	Geode Capital Management LLC	141,335	$0.67M	0.0%	+73.1%	0.380%
5/12/2021	Salzhauer Michael	37,303	$0.18M	0.1%	+36.6%	0.100%
5/6/2021	Sigma Planning Corp	14,502	$69K	0.0%	-55.8%	0.039%
2/16/2021	One68 Global Capital LLC	22,261	$0.14M	0.3%	N/A	0.080%
2/16/2021	Price T Rowe Associates Inc. MD	11,400	$74K	0.0%	-33.2%	0.041%
2/16/2021	Avidity Partners Management LP	1,952,000	$12.59M	0.4%	N/A	6.974%
2/16/2021	ExodusPoint Capital Management LP	18,854	$0.12M	0.0%	N/A	0.067%
2/12/2021	Sandbox Financial Partners LLC	75,000	$0.48M	0.4%	N/A	0.268%
2/11/2021	Northern Trust Corp	27,310	$0.18M	0.0%	+94.9%	0.098%
2/10/2021	Renaissance Technologies LLC	318,906	$2.06M	0.0%	-20.8%	1.139%
2/9/2021	Sigma Planning Corp	32,802	$0.21M	0.0%	-26.0%	0.117%
2/5/2021	BlackRock Inc.	60,526	$0.39M	0.0%	+109.1%	0.216%
1/30/2021	Salzhauer Michael	27,303	$0.18M	0.1%	-15.5%	0.098%
12/11/2020	Virtu Financial LLC	10,167	$34K	0.0%	N/A	0.036%
11/19/2020	Schonfeld Strategic Advisors LLC	27,900	$95K	0.0%	N/A	0.100%
11/17/2020	Schonfeld Strategic Advisors LLC	27,900	$94K	0.0%	N/A	0.101%
11/6/2020	BlackRock Inc.	28,941	$98K	0.0%	-45.7%	0.105%
11/3/2020	Sigma Planning Corp	44,302	$0.15M	0.0%	-8.3%	0.160%
8/10/2020	D.A. Davidson & CO.	118,500	$0.24M	0.0%	+74.9%	0.515%
7/31/2020	Sigma Planning Corp	48,302	$99K	0.0%	+75.6%	0.210%
5/1/2020	Sigma Planning Corp	27,502	$35K	0.0%	N/A	0.121%
2/13/2020	Renaissance Technologies LLC	198,519	$0.36M	0.0%	+116.5%	1.853%
2/10/2020	Salzhauer Michael	32,303	$58K	0.0%	+127.5%	0.302%
11/6/2019	Salzhauer Michael	14,200	$28K	0.0%	N/A	0.133%
11/5/2019	D.A. Davidson & CO.	24,000	$47K	0.0%	N/A	0.225%
8/14/2019	Citadel Advisors LLC	13,073	$33K	0.0%	N/A	0.123%
8/14/2019	Worth Venture Partners LLC	39,241	$99K	0.1%	N/A	0.370%
8/14/2019	Vanguard Group Inc.	174,640	$0.44M	0.0%	-81.3%	1.645%
8/14/2019	Private Advisor Group LLC	10,500	$27K	0.0%	N/A	0.099%
8/13/2019	BlackRock Inc.	32,568	$82K	0.0%	-93.2%	0.307%
8/13/2019	Northern Trust Corp	11,441	$29K	0.0%	-90.0%	0.108%
8/7/2019	JPMorgan Chase & Co.	18,085	$46K	0.0%	N/A	0.170%
2/15/2019	Millennium Management LLC	40,051	$26K	0.0%	-43.0%	0.062%
2/13/2019	Geode Capital Management LLC	388,688	$0.25M	0.0%	+72.5%	0.603%
2/12/2019	Northern Trust Corp	114,921	$73K	0.0%	+33.6%	0.178%
2/11/2019	Moloney Securities Asset Management LLC	50,000	$32K	0.0%	+117.4%	0.078%
2/11/2019	Bank of New York Mellon Corp	100,325	$64K	0.0%	+484.1%	0.156%
2/8/2019	BlackRock Inc.	485,983	$0.31M	0.0%	+98.2%	0.753%
11/15/2018	Nexthera Capital LP	1,388,824	$1.94M	0.4%	-46.9%	2.345%
11/15/2018	Point72 Asset Management L.P.	1,825,985	$2.56M	0.0%	-17.6%	3.083%
9/17/2018	683 Capital Management LLC	300,000	$0.41M	0.0%	N/A	0.573%
8/15/2018	Millennium Management LLC	1,195,315	$1.65M	0.0%	+19.5%	2.283%
8/15/2018	Nexthera Capital LP	2,614,297	$3.61M	0.6%	+26.6%	4.994%
8/14/2018	Point72 Asset Management L.P.	2,215,000	$3.06M	0.0%	-31.1%	4.231%
8/14/2018	DRW Securities LLC	180,000	$0.25M	0.0%	+157.1%	0.344%
8/9/2018	BlackRock Inc.	238,940	$0.33M	0.0%	+1,303.5%	0.456%
5/16/2018	Millennium Management LLC	1,000,576	$1.88M	0.0%	+2,073.8%	1.944%
5/16/2018	Nexthera Capital LP	2,064,297	$3.88M	0.6%	N/A	4.010%
5/15/2018	Point72 Asset Management L.P.	3,215,000	$6.04M	0.0%	+47.5%	6.245%
5/15/2018	venBio Select Advisor LLC	4,007,696	$7.53M	0.4%	N/A	7.785%
5/15/2018	Sofinnova Ventures Inc	66,965	$0.13M	0.0%	N/A	0.130%
5/14/2018	DRW Securities LLC	70,000	$0.13M	0.0%	N/A	0.136%
5/14/2018	Commonwealth Equity Services LLC	76,510	$0.14M	0.0%	+97.6%	0.149%
2/16/2018	J. Goldman & Co LP	100,000	$0.16M	0.0%	N/A	0.233%
2/15/2018	Sabby Management LLC	153,137	$0.25M	0.0%	-84.8%	0.357%
2/14/2018	Deutsche Bank AG	160,759	$0.26M	0.0%	N/A	0.374%
2/13/2018	Renaissance Technologies LLC	167,093	$0.27M	0.0%	N/A	0.389%
2/13/2018	MYDA Advisors LLC	89,000	$0.15M	0.1%	N/A	0.207%
5/15/2017	Sabby Management LLC	975,839	$1.26M	0.1%	-16.9%	4.676%
2/13/2017	Renaissance Technologies LLC	95,000	$0.12M	0.0%	-39.6%	0.481%
8/15/2016	Sabby Management LLC	608,052	$1M	0.1%	-45.3%	3.448%
5/13/2016	Sabby Management LLC	1,111,348	$2.83M	0.1%	-9.2%	6.549%
5/13/2016	Renaissance Technologies LLC	43,400	$0.11M	0.0%	N/A	0.256%
5/13/2016	Geode Capital Management LLC	57,031	$0.15M	0.0%	No Change	0.336%
2/16/2016	Ridgeback Capital Investments L.P.	1,292,614	$3.06M	13.2%	N/A	7.617%

Data available starting January 2016

OncoSec Medical Incorporated, a late-stage immuno-oncology company, focuses on designing, developing, commercializing intra-tumoral DNA-based therapeutics to stimulate and augment anti-tumor immune responses for the treatment of cancer. The company's lead product candidate is ImmunoPulse IL-12 that uses electroporation device to deliver a DNA-encoded interleukin-12 for reversing the immunosuppressive microenvironment in the treated tumor. It is also developing ImmunoPulse IL-12 with KEYTRUDA in patients with advanced melanoma that is in clinical trials collaboration and supply agreement (KEYNOTE-695) and metastatic triple negative breast cancer, which is in Phase II clinical trials (KEYNOTE-890); ImmunoPulse IL-12 and KEYTRUDA in patients with advanced or metastatic melanoma that has completed Phase II clinical trials; and ImmunoPulse IL-12 monotherapy in patients with metastatic melanoma, which has completed the Phase II clinical trials. In addition, the company is developing monotherapy biomarker study in patients with advanced or metastatic TNBC that has completed the Phase II clinical trials; and technology to treat liver, lung, bladder, pancreatic, and other visceral lesions. OncoSec Medical Incorporated has clinical trial collaborations with Merck & Co., Inc. and its subsidiary in connection with the KEYNOTE-695 and KEYNOTE-890 studies; a research collaboration with Duke University's Center for Applied Therapeutics to evaluate TAVO in combination or sequenced with a HER2-plasmid vaccine; a research collaboration with Roswell Park Comprehensive Cancer Center to evaluate the use of Roswell Park's intravital microscopy and enhanced IL-12 DNA-plasmid; and collaboration with Providence Cancer Institute. The company was formerly known as NetVentory Solutions Inc. and changed its name to OncoSec Medical Incorporated in March 2011. The company was incorporated in 2008 and is headquartered in Pennington, New Jersey.

Today's Range

Now: $0.72

$0.70

$0.72

50 Day Range

MA: $0.78

$0.71

$0.90

52 Week Range

Now: $0.72

$0.67

$2.42

Volume

16,121 shs

Average Volume

77,828 shs

Market Capitalization

$28.34 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.89

Who are the company insiders with the largest holdings of OncoSec Medical?: OncoSec Medical's top insider shareholders include:
Alpha Holdings, Inc (Director)
Brian A Leuthner (CEO)
Daniel J O'connor (CEO)
Robert J Delaversano (VP)
Robert J Delaversano (VP)
Yuhang Zhao (Director)
Grand Pharmaceutical & H China (Major Shareholder)
Learn More about top insider investors at OncoSec Medical.
Who are the major institutional investors of OncoSec Medical?: OncoSec Medical's top institutional shareholders include:
Renaissance Technologies LLC — 0.19%
Concourse Financial Group Securities Inc. — 0.00%
Learn More about top institutional investors of OncoSec Medical stock.
Which major investors are buying OncoSec Medical stock?: In the last quarter, ONCS stock was purchased by institutional investors including:
Renaissance Technologies LLC
Within the previous year, these company insiders have bought OncoSec Medical stock:
Alpha Holdings, Inc (Director)
Brian A Leuthner (CEO)
Learn More investors buying OncoSec Medical stock.

Most profitable less than $5 stock in the world?